The wound care management market comprises of dressings, equipment and other aids to prevent and treat wounds and quicken or promote wound healing. Surgical sutures are used to hold tissues together after injury or surgery to enhance the natural healing process. GlobalData uses proprietary data and analytics to provide a comprehensive report on the surgical sutures market in China. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the surgical sutures market in China was Arthrex followed by Assut Medical, B. Braun Melsungen, Covidien Holding, Ethicon, Gunze and Smith & Nephew.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Surgical sutures are commonly used on the skin, internal tissues, organs and blood vessels. Automated suturing devices and sutures are covered under this category.
The surgical sutures market in China can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size surgical sutures in China, buy the report here.